Conference
PCN68 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUXTM) FOR THE FIRST LINE TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN CANADA
Authors
Sambrook J; Levy A; Johnston K; Ricard N; Bourgault C; Donato B; Hotte S; Chasen; Briggs A
Volume
12
Publisher
Elsevier
Publication Date
5 2009
DOI
10.1016/s1098-3015(10)73305-2
Conference proceedings
Value in Health
Issue
3
ISSN
1098-3015